Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  hepatitis B vaccine (recombinant)
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
Phase: Phase III
Type: Prevention
Status: Completed
Age: 20 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111567, NCT00637195
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 9 to 15
Sponsor: Pharmaceutical / Industry
Protocol IDs: 111507, NCT00652938
Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 26 to 45
Sponsor: Pharmaceutical / Industry
Protocol IDs: 114590, NCT01277042
Modified Process Hepatitis B Vaccine in Healthy Neonates
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 10 days and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2006_007, V232-056, NCT00322361
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 2 to 18
Sponsor: Other
Protocol IDs: 07-088, NCT00505063
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 25
Sponsor: Other
Protocol IDs: HPV-PRO-002, NCT01356823
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Phase: No phase specified
Type: Natural history/Epidemiology, Prevention
Status: Completed
Age: 21 to 30
Sponsor: NCI
Protocol IDs: 999910059, 10-C-N059, NCT01086709
Start Over